Novo Holdings is investing in biotech with great confidence in the market
Amolyt specializes in developing therapeutic peptides for rare hormone diseases and related diseases. Although rare diseases only affect a small portion of the population, they can have serious consequences for patients. Amolyt therefore focuses on developing effective treatments for these patients.
Novo Holdings is investing in biotech with great confidence in the market Read More »









